These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6552857)

  • 21. Determination of Hageman factor (HG, factor XII) and plasma prekallikrein (Fletcher factor) by radioimmunoassays.
    Saito H
    Adv Exp Med Biol; 1979; 120A():165-72. PubMed ID: 573961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A quarter century with Mr. Hageman.
    Ratnoff OD
    Thromb Haemost; 1980 Jun; 43(2):95-8. PubMed ID: 7006141
    [No Abstract]   [Full Text] [Related]  

  • 23. Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein.
    Meier HL; Pierce JV; Colman RW; Kaplan AP
    J Clin Invest; 1977 Jul; 60(1):18-31. PubMed ID: 874082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surface and fluid phase activities of two forms of activated Hageman factor produced during contact activation of plasma.
    Revak SD; Cochrane CG; Bouma BN; Griffin JH
    J Exp Med; 1978 Mar; 147(3):719-29. PubMed ID: 632748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deficiency of factor XII-dependent plasminogen proactivator in prekallikrein-deficient plasma.
    Bouma BN; Griffin JH
    J Lab Clin Med; 1978 Jan; 91(1):148-55. PubMed ID: 73563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prekallikrein activation and high-molecular-weight kininogen consumption in hereditary angioedema.
    Schapira M; Silver LD; Scott CF; Schmaier AH; Prograis LJ; Curd JG; Colman RW
    N Engl J Med; 1983 May; 308(18):1050-3. PubMed ID: 6601240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Initiation of contact system activation in plasma is dependent on factor XII autoactivation and not on enhanced susceptibility of factor XII for kallikrein cleavage.
    Citarella F; Wuillemin WA; Lubbers YT; Hack CE
    Br J Haematol; 1997 Oct; 99(1):197-205. PubMed ID: 9359524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding and activation properties of human factor XII, prekallikrein, and derived peptides with acidic lipid vesicles.
    Griep MA; Fujikawa K; Nelsestuen GL
    Biochemistry; 1985 Jul; 24(15):4124-30. PubMed ID: 3876845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of factor XII by dextran sulfate: the basis for an assay of factor XII.
    Tankersley DL; Alving BM; Finlayson JS
    Blood; 1983 Aug; 62(2):448-56. PubMed ID: 6191802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The bradykinin-forming cascade: a historical perspective.
    Kaplan AP
    Chem Immunol Allergy; 2014; 100():205-13. PubMed ID: 24925400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen.
    Revak SD; Cochrane CG; Griffin JH
    J Clin Invest; 1977 Jun; 59(6):1167-75. PubMed ID: 864009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunochemical studies of plasma kallikrein.
    Bagdasarian A; Lahiri B; Talamo RC; Wong P; Colman RW
    J Clin Invest; 1974 Dec; 54(6):1444-54. PubMed ID: 4140197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Plasma kallikrein: new functions].
    Paskhina TS
    Biokhimiia; 1976 Aug; 41(8):1347-51. PubMed ID: 1030643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of the contact system in ascites from patients with gastrointestinal cancer.
    Buø L; Karlsrud TS; Johansen HT; Aasen AO
    Agents Actions Suppl; 1992; 38 ( Pt 2)():237-48. PubMed ID: 1281373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma prekallikrein activity in patients with total hip arthroplasty.
    Hoffmann JJ; Kortmann JH
    Thromb Haemost; 1987 Dec; 58(4):1040-2. PubMed ID: 3445224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of hageman factor and prekallikrein and generation of kinin by various microbial proteinases.
    Molla A; Yamamoto T; Akaike T; Miyoshi S; Maeda H
    J Biol Chem; 1989 Jun; 264(18):10589-94. PubMed ID: 2499581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The contact system in human malignant and benign ascites.
    Buø L; Karlsrud TS; Johansen HT; Aasen AO
    Scand J Clin Lab Invest; 1993 Apr; 53(2):117-24. PubMed ID: 7682333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prekallikein and kallikrein inhibitor in liver cirrhosis and hepatitis.
    Faciullacci M; Galli P; Monetti MG; Pela I; Del Bianco PL
    Adv Exp Med Biol; 1976; 70(00):201-8. PubMed ID: 1084679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The mechanism of activation of kallikrein-kinin system in the plasma of patients with atopic allergic diseases].
    Dotsenko VL; Nenasheva NM; Neshkova EA; Morozova NA; Iarovaia GA
    Vopr Med Khim; 1988; 34(6):89-94. PubMed ID: 3238945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of human Hageman factor by a leukocytic protease.
    Newball HH; Revak SD; Cochrane CG; Griffin JH; Lichtenstein LM
    Adv Exp Med Biol; 1979; 120B():139-51. PubMed ID: 517231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.